← Eichor
Condition: Imipramine Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Imipramine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subj
Phase 1 · 1 location(s) · Wright State University · NCT04520217The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans
Phase 2 · 1 location(s) · VA Office of Research and Development · NCT06778434The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy
Phase 1 · 1 location(s) · Wright State University · NCT05688904New Treatment for Nocturnal Enuresis in Children
NA · 1 location(s) · Sohag University · NCT06497647Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
Phase 2 · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT04863950Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With
Phase 2 · 1 location(s) · Wright State University · NCT06312813
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.